Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Virtual play therapy aims to boost motor skills and social life in young leukemia survivors

NCT ID NCT07522905

First seen May 01, 2026 · Last updated Jun 22, 2026 · Updated 8 times

Summary

This study tests a 12-week virtual buddy-movement therapy for children aged 5 to 12 who have finished treatment for acute lymphoblastic leukemia. The program pairs each child with a healthy buddy for twice-weekly movement sessions designed to improve motor skills, coordination, and quality of life. Researchers will measure changes in motor proficiency and emotional/social functioning, comparing a group that does the therapy to a control group that does not.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institute of Children´s Diseases

    RECRUITING

    Bratislava, 83340, Slovakia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Virtual buddy-movement therapy (behavioral intervention)

What this could lead to

If it works, this could offer a fun, social way to help children recovering from leukemia improve their movement, coordination, and emotional well-being.

What could go wrong

This is a small early study with only 24 participants, so results may not apply to all children. The therapy is behavioral, so benefits depend on participation and may be modest.

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma precursor lymphoblastic lymphoma/leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.